Atossa Therapeutics (ATOS) Stock Chart & Stock Price History → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free ATOS Stock Alerts $1.66 +0.14 (+9.21%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Atossa Therapeutics Stock Price Performance5 Day Performance+9.93%1 Month Performance-11.23%3 Month Performance+98.80%6 Month Performance+137.14%Year-To-Date Performance+88.64%1 Year Performance+141.98% Receive ATOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad AltimetryStock-Picking AI Predicts #1 Stock of 2024Since the start of the year, the top 10 investment funds in the world – including Vanguard, Blackrock, Fidelity and JP Morgan – have made nearly $1 trillion in profits on these 7 stocks.Click here to learn what's coming (and how to prepare). ATOS Stock Chart for Sunday, May, 5, 2024 ATOS Chart by TradingView Atossa Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$1.52$1.66+9.21%$1.70$1.531.36 million shs$208.01 million05/02/2024$1.53$1.52-0.65%$1.57$1.491.19 million shs$190.46 million05/01/2024$1.51$1.53+1.32%$1.54$1.47966,152 shs$191.71 million04/30/2024$1.53$1.51-1.31%$1.59$1.471.35 million shs$189.20 million04/29/2024$1.53$1.53$1.58$1.521.03 million shs$191.71 million04/26/2024$1.52$1.53+0.66%$1.60$1.51898,654 shs$191.71 million Get the Latest News and Ratings for ATOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$1.50$1.52+1.33%$1.57$1.45854,366 shs$190.46 million04/24/2024$1.49$1.50+0.67%$1.60$1.482.33 million shs$187.95 million04/23/2024$1.42$1.49+4.93%$1.51$1.411.16 million shs$186.70 million04/22/2024$1.37$1.42+3.65%$1.47$1.321.02 million shs$177.93 million04/19/2024$1.42$1.37-3.52%$1.43$1.331.21 million shs$171.67 million04/18/2024$1.35$1.42+5.19%$1.48$1.242.32 million shs$177.93 million04/17/2024$1.54$1.35-12.34%$1.62$1.354.06 million shs$169.16 million04/16/2024$1.71$1.54-9.94%$1.69$1.531.71 million shs$192.96 million04/15/2024$1.66$1.71+3.01%$1.73$1.631.61 million shs$214.26 million04/12/2024$1.77$1.66-6.21%$1.83$1.602.00 million shs$208.00 million04/11/2024$1.75$1.77+1.14%$1.84$1.74979,272 shs$221.78 million04/10/2024$1.84$1.75-4.89%$1.82$1.721.64 million shs$219.28 million04/09/2024$1.75$1.84+5.14%$1.97$1.703.86 million shs$230.55 million04/08/2024$1.87$1.75-6.42%$1.91$1.634.05 million shs$219.28 million04/05/2024$2.10$1.87-10.95%$2.30$1.6010.57 million shs$234.32 million04/04/2024$2.03$2.10+3.70%$2.27$2.034.02 million shs$263.13 million04/03/2024$1.84$2.03+10.05%$2.07$1.812.38 million shs$253.73 million04/02/2024$2.00$1.84-8.00%$2.04$1.823.55 million shs$230.55 million04/01/2024$1.80$2.00+11.11%$2.11$1.783.42 million shs$250.60 million03/29/2024$1.80$1.80$1.91$1.761.89 million shs$225.54 million03/28/2024$1.83$1.80-1.64%$1.91$1.761.89 million shs$225.54 million03/27/2024$1.80$1.83+1.67%$1.87$1.702.55 million shs$229.30 million03/26/2024$1.89$1.80-4.76%$1.94$1.723.75 million shs$225.54 million03/25/2024$1.67$1.89+13.17%$1.89$1.613.18 million shs$236.82 million03/22/2024$1.68$1.67-0.60%$1.70$1.571.86 million shs$209.25 million03/21/2024$1.63$1.68+3.07%$1.70$1.572.54 million shs$210.50 million03/20/2024$1.55$1.63+5.16%$1.73$1.536.81 million shs$204.25 million03/19/2024$1.29$1.55+20.16%$1.57$1.294.58 million shs$194.22 million03/18/2024$1.29$1.29$1.34$1.24817,518 shs$161.64 million03/15/2024$1.20$1.29+7.50%$1.30$1.151.20 million shs$161.64 million03/14/2024$1.26$1.20-4.76%$1.27$1.10774,466 shs$150.36 million03/13/2024$1.31$1.26-3.82%$1.32$1.121.51 million shs$157.88 million03/12/2024$1.20$1.31+9.17%$1.33$1.212.32 million shs$164.14 million03/11/2024$1.09$1.20+10.09%$1.25$1.101.49 million shs$150.36 millionCharles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/08/2024$1.10$1.09-0.91%$1.17$1.081.14 million shs$136.58 million03/07/2024$1.15$1.10-4.35%$1.25$1.081.66 million shs$137.83 million03/06/2024$1.02$1.15+12.75%$1.20$1.022.91 million shs$144.10 million03/05/2024$1.02$1.02$1.03$0.99301,201 shs$127.81 million03/04/2024$1.00$1.02+2.00%$1.04$0.99511,907 shs$127.81 million03/01/2024$0.98$1.00+2.35%$1.02$0.98332,890 shs$125.30 million02/29/2024$1.00$0.98-2.30%$1.02$0.97410,236 shs$122.42 million02/28/2024$1.03$1.00-2.91%$1.04$1.00480,190 shs$125.30 million02/27/2024$0.98$1.03+5.09%$1.03$0.96503,802 shs$129.06 million02/26/2024$0.98$0.98+0.01%$1.00$0.96304,056 shs$122.81 million02/23/2024$1.02$0.98-3.92%$1.02$0.97459,857 shs$122.79 million02/22/2024$1.01$1.02+0.99%$1.05$1.00522,375 shs$127.81 million02/21/2024$1.02$1.01-0.98%$1.02$0.95369,357 shs$126.56 million02/20/2024$1.01$1.02+0.99%$1.03$0.99490,219 shs$127.81 million02/19/2024$1.01$1.01$1.02$0.97319,000 shs$126.55 million02/16/2024$1.01$1.01$1.02$0.97317,633 shs$126.55 million02/15/2024$1.03$1.01-1.94%$1.05$0.99506,823 shs$126.55 million02/14/2024$0.97$1.03+6.19%$1.03$0.98575,298 shs$129.06 million02/13/2024$0.99$0.97-2.02%$1.02$0.95546,203 shs$121.54 million02/12/2024$0.94$0.99+5.80%$1.05$0.95874,278 shs$124.05 million02/09/2024$0.94$0.94-0.46%$0.94$0.90228,217 shs$117.24 million02/08/2024$0.95$0.94-0.77%$0.98$0.93406,110 shs$117.78 million02/07/2024$0.90$0.95+5.84%$0.95$0.90758,088 shs$118.70 million02/06/2024$0.84$0.90+7.19%$0.90$0.84249,018 shs$112.15 million02/05/2024$0.85$0.84-2.11%$0.85$0.83228,215 shs$104.63 million Related Companies: VERU Stock Price Chart ALIM Stock Price Chart OMER Stock Price Chart LFCR Stock Price Chart TRVI Stock Price Chart ZVRA Stock Price Chart RIGL Stock Price Chart SKYE Stock Price Chart IVA Stock Price Chart ACET Stock Price Chart Receive ATOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATOS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsAutomatic Income (from home)Awesomely, LLCCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.